 <h1>Prepopik Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>citric acid / magnesium oxide / sodium picosulfate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about citric acid / magnesium oxide / sodium picosulfate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Prepopik.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to citric acid/magnesium oxide/sodium picosulfate: oral powder for solution, oral solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, citric acid / magnesium oxide / sodium picosulfate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking citric acid / magnesium oxide / sodium picosulfate:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding of the rectum</li>
<li>bloody stools</li>
<li>confusion</li>
<li>cough</li>
<li>decreased urine output</li>
<li>diarrhea</li>
<li>dizziness or fainting</li>
<li>dry mouth</li>
<li>fast, slow, or irregular heartbeat</li>
<li>fever</li>
<li>headache</li>
<li>hives, itching, skin rash</li>
<li>increased thirst</li>
<li>jerking or shaking of the muscles</li>
<li>joint pain, stiffness, or swelling</li>
<li>loss of bowel control</li>
<li>loss of consciousness</li>
<li>muscle pain or cramps</li>
<li>nausea</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>pinpoint red or purple spots on the skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>seizures</li>
<li>stomach pain and tenderness</li>
<li>swelling of the eyelids, face, lips, ankles, hands, or feet</li>
<li>tightness in the chest</li>
<li>troubled breathing or swallowing</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of citric acid / magnesium oxide / sodium picosulfate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Pain in the rectum</li>
</ul><p>
<!-- end oral powder for solution, oral solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to citric acid / magnesium oxide / sodium picosulfate: oral powder for reconstitution, oral solution</i></p><h3>General</h3><p>The most commonly reported side effects included headache, nausea, vomiting, and proctalgia.<sup>[Ref]</sup></p><h3>Renal</h3><p>Low GFR occurred in 28.5% of patients using the day-before regimen compared to 25.1% of patients using the split-dose regimen at 24 to 48 hours after the colonoscopy.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Low glomerular filtration rate (up to 28.5%)</p>
<p><b>Common</b> (1% to 10%): High creatinine<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Orthostatic changes (up to 20%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension</p>
<p><b>Frequency not reported</b>: Cardiac arrhythmias<sup>[Ref]</sup></p><p>Orthostatic changes included changes in blood pressure and heart rate.</p>
<p></p>
<p>In a study, approximately 20% of pediatric patients 9 to 16 years of age given this drug had orthostatic changes for up to 5 days compared to 7% of patients given the comparator drug regimen (polyethylene glycol and electrolytes solution plus bisacodyl).<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypermagnesemia (up to 11.6%)</p>
<p><b>Common</b> (1% to 10%): Electrolyte abnormalities, hypochloremia, hypokalemia, hyponatremia, thirst</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypocalcemia</p>
<p><b>Frequency not reported</b>: Abnormally low glucose levels (40 to 47 mg/dL), dehydration, serious fluid and electrolyte abnormalities<sup>[Ref]</sup></p><p>Hypermagnesemia occurred in 11.6% of patients using the split-dose regimen compared to 8.7% of patients using the day-before regimen the day of the colonoscopy.</p>
<p></p>
<p>Abnormally low glucose levels were reported in asymptomatic pediatric patients, with one occurring at the colonoscopy, and one at the 5-day follow-up visit.</p>
<p></p>
<p>Hyponatremia has occurred with/without convulsions.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal distention, abdominal fullness, abdominal pain, anal discomfort, bloating, dry mouth, nausea, proctalgia, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal cramps, anal irritation, aphthoid ileal ulcers/mild reversible aphthoid ileal ulcers, diarrhea, ileal ulcers.  fecal incontinence</p>
<p><b>Rare</b> (0.01% to 0.1%): Anal incontinence</p>
<p><b>Frequency not reported</b>: Abdominal bloating, colonic mucosal ulceration, flatulence, ischemic colitis, ulcerative colitis, watery diarrhea</p>
<p><b>Postmarketing reports</b>: Severe diarrhea<sup>[Ref]</sup></p><p>Since abdominal bloating, distention, pain/cramping, and watery diarrhea were predicted to occur as part of the colon cleansing regimen, these side effects were included only if patients required medical attention or the condition significantly worsened during the study and was not in the frame of the usual clinical course.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Generalized tonic-clonic seizures occurred with and without hyponatremia in patients with epilepsy.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Convulsions, decreased/loss of consciousness, dizziness, epilepsy, generalized tonic-clonic seizures, grand mal convulsion, seizures, syncope</p>
<p><b>Rare</b> (0.01% to 0.1%): Presyncope<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Sleep disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Confusional state, disorientation</p>
<p><b>Frequency not reported</b>: Sleep disturbance<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Frequency not reported</b>: Pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Erythematous rash, maculopapular rash, purpura, rash, urticaria</p>
<p><b>Frequency not reported</b>: Pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction, hypersensitivity</p>
<p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Aspiration</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc, Tarrytown, NY. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the difference between Clenpiq and Prepopik?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Prepopik (citric acid / magnesium oxide / sodium picosulfate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>En Espa√±ol</li>
<li>156 Reviews</li>
<li>Drug class: laxatives</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prepopik &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Clenpiq</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bowel Preparation</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to citric acid / magnesium oxide / sodium picosulfate: oral powder for reconstitution, oral solution</i></p><h3>General</h3><p>The most commonly reported side effects included headache, nausea, vomiting, and proctalgia.<sup>[Ref]</sup></p><h3>Renal</h3><p>Low GFR occurred in 28.5% of patients using the day-before regimen compared to 25.1% of patients using the split-dose regimen at 24 to 48 hours after the colonoscopy.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Low glomerular filtration rate (up to 28.5%)</p><p><b>Common</b> (1% to 10%): High creatinine<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Orthostatic changes (up to 20%)</p><p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension</p><p><b>Frequency not reported</b>: Cardiac arrhythmias<sup>[Ref]</sup></p><p>Orthostatic changes included changes in blood pressure and heart rate.</p><p></p><p>In a study, approximately 20% of pediatric patients 9 to 16 years of age given this drug had orthostatic changes for up to 5 days compared to 7% of patients given the comparator drug regimen (polyethylene glycol and electrolytes solution plus bisacodyl).<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypermagnesemia (up to 11.6%)</p><p><b>Common</b> (1% to 10%): Electrolyte abnormalities, hypochloremia, hypokalemia, hyponatremia, thirst</p><p><b>Uncommon</b> (0.1% to 1%): Hypocalcemia</p><p><b>Frequency not reported</b>: Abnormally low glucose levels (40 to 47 mg/dL), dehydration, serious fluid and electrolyte abnormalities<sup>[Ref]</sup></p><p>Hypermagnesemia occurred in 11.6% of patients using the split-dose regimen compared to 8.7% of patients using the day-before regimen the day of the colonoscopy.</p><p></p><p>Abnormally low glucose levels were reported in asymptomatic pediatric patients, with one occurring at the colonoscopy, and one at the 5-day follow-up visit.</p><p></p><p>Hyponatremia has occurred with/without convulsions.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal distention, abdominal fullness, abdominal pain, anal discomfort, bloating, dry mouth, nausea, proctalgia, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal cramps, anal irritation, aphthoid ileal ulcers/mild reversible aphthoid ileal ulcers, diarrhea, ileal ulcers.  fecal incontinence</p><p><b>Rare</b> (0.01% to 0.1%): Anal incontinence</p><p><b>Frequency not reported</b>: Abdominal bloating, colonic mucosal ulceration, flatulence, ischemic colitis, ulcerative colitis, watery diarrhea</p><p><b>Postmarketing reports</b>: Severe diarrhea<sup>[Ref]</sup></p><p>Since abdominal bloating, distention, pain/cramping, and watery diarrhea were predicted to occur as part of the colon cleansing regimen, these side effects were included only if patients required medical attention or the condition significantly worsened during the study and was not in the frame of the usual clinical course.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Generalized tonic-clonic seizures occurred with and without hyponatremia in patients with epilepsy.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Convulsions, decreased/loss of consciousness, dizziness, epilepsy, generalized tonic-clonic seizures, grand mal convulsion, seizures, syncope</p><p><b>Rare</b> (0.01% to 0.1%): Presyncope<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Sleep disorder</p><p><b>Uncommon</b> (0.1% to 1%): Confusional state, disorientation</p><p><b>Frequency not reported</b>: Sleep disturbance<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Frequency not reported</b>: Pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Erythematous rash, maculopapular rash, purpura, rash, urticaria</p><p><b>Frequency not reported</b>: Pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction, hypersensitivity</p><p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Aspiration</p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc, Tarrytown, NY. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the difference between Clenpiq and Prepopik?</li>
</ul><h2>More about Prepopik (citric acid / magnesium oxide / sodium picosulfate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>En Espa√±ol</li>
<li>156 Reviews</li>
<li>Drug class: laxatives</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prepopik &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bowel Preparation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>